Sirolimus-eluting stents remain superior to bare-metal stents at two years: medium-term results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. (Q51236294)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sirolimus-eluting stents remain superior to bare-metal stents at two years: medium-term results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. |
scientific article |
Statements
Sirolimus-eluting stents remain superior to bare-metal stents at two years: medium-term results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. (English)
1 reference
1 reference
Patrick W Serruys
1 reference
Andrew T L Ong
1 reference
Ron T van Domburg
1 reference
Jiro Aoki
1 reference
Karel Sonnenschein
1 reference
20 March 2006
1 reference
47
1 reference
7
1 reference
1356-1360
1 reference